Advanced search
Publication Cover
Modern Rheumatology Volume 31, 2021 - Issue 4
Journal homepage
510
Views
7
CrossRef citations to date
0
Altmetric
Connective tissue diseases and related disorders

Efficacy and safety of apremilast for 3 months in Behçet’s disease: A prospective observational study

Lisa Hiraharaa Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, JapanView further author information
,
Yohei Kirinoa Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9488-661XView further author information
ORCID Icon,
Yutaro Soejimaa Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, JapanView further author information
,
Mitsuhiro Takenob Nippon Medical School Musashi Kosugi Hospital, Department of Allergy and Rheumatology, Kawasaki, JapanView further author information
,
Kaoru Takase-Minegishia Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, JapanView further author information
,
Ryusuke Yoshimia Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, JapanView further author information
,
Masaki Takeuchic Department of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, Yokohama, JapanView further author information
,
Nobuhisa Mizukic Department of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, Yokohama, JapanView further author information
&
Hideaki Nakajimaa Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, JapanView further author information
 show all
Pages 856-861 | Received 02 Sep 2020, Accepted 24 Sep 2020, Published online: 16 Oct 2020

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Yesim Ozguler, Sinem Nihal Esatoglu & Gulen Hatemi. (2023) Current pharmacological solutions for Behçet’s syndrome. Expert Opinion on Pharmacotherapy 24:2, pages 221-231.
Read now
Ayşe Özdede & Gülen Hatemi. (2021) An evaluation of apremilast for the treatment of adult patients with oral ulcers associated with Behçet’s syndrome. Expert Opinion on Pharmacotherapy 22:12, pages 1533-1537.
Read now

Articles from other publishers (5)

Theodoros Xenitidis & Jörg Christoph Henes. (2023) Neues zum Behçet-Syndrom. DMW - Deutsche Medizinische Wochenschrift 148:17, pages 1129-1134.
Crossref
Risa Wakiya, Yusuke Ushio, Kiyo Ueeda, Tomohiro Kameda, Hiromi Shimada, Shusaku Nakashima, Mikiya Kato, Taichi Miyagi, Koichi Sugihara, Mao Mizusaki, Rina Mino, Norimitsu Kadowaki & Hiroaki Dobashi. (2022) Efficacy and safety of apremilast and its impact on serum cytokine levels in patients with Behçet's disease. Dermatologic Therapy 35:8.
Crossref
Yuki Iizuka, Kaoru Takase-Minegishi, Lisa Hirahara, Yohei Kirino, Yutaro Soejima, H o Namkoong, Nobuyuki Horita, Ryusuke Yoshimi, Masaki Takeuchi, Mitsuhiro Takeno, Nobuhisa Mizuki & Hideaki Nakajima. (2021) Beneficial effects of apremilast on genital ulcers, skin lesions, and arthritis in patients with Behçet’s disease: A systematic review and meta-analysis. Modern Rheumatology.
Crossref
Fatma Alibaz-Oner & Haner Direskeneli. (2021) Advances in the Treatment of Behcet’s Disease. Current Rheumatology Reports 23:6.
Crossref
Matheus Vieira, Solène Buffier, Mathieu Vautier, Alexandre Le Joncour, Yvan Jamilloux, Mathieu Gerfaud-Valentin, Laurence Bouillet, Estibaliz Lazaro, Stéphane Barete, Laurent Misery, Delphine Gobert, Tiphaine Goulenok, Olivier Fain, Karim Sacre, Pascal Sève, Patrice Cacoub, Cloé Comarmond & David Saadoun. (2021) Apremilast in Refractory Behçet’s Syndrome: A Multicenter Observational Study. Frontiers in Immunology 11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.